Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C O Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112266365A reveals a metal-free oxidative coupling method for high-purity phenoxazine intermediates, offering significant cost reduction in organic photoelectric material manufacturing.
Novel catalytic method enhances benzamide compound purity and yield. Offers significant supply chain stability and cost reduction in API manufacturing for global partners.
Novel Ni-catalyzed method for trifluoroethylation using cheap 2-chloro-1,1,1-trifluoroethane. Mild conditions, high yield, suitable for pharma intermediates.
Patent CN109438402B discloses a green catalytic route for benzofuranone derivatives. High yield, low cost, scalable process ideal for pharmaceutical intermediates manufacturing.
Novel 2-step synthesis of Montelukast intermediate via Wittig and Pd-coupling. Reduces cost and steps for API manufacturing.
Novel Ni-catalyzed route for Bilastine intermediate II. High yield, low cost, scalable process replacing Palladium methods for pharmaceutical manufacturing.
Novel nickel-catalyzed method for diaryl ketones. High purity, scalable process for pharmaceutical intermediates. Cost-effective supply chain solution.
Novel nitro-based cross-coupling method eliminates halogen waste. Offers cost reduction in pharmaceutical intermediate manufacturing and high-purity aromatic compounds for global supply chains.
Patent CN112174832A details a novel one-step Pd-catalyzed methylation route for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Novel one-pot synthesis reduces costs and improves yield for high-purity pharmaceutical intermediates. Environmentally friendly process ensures supply chain reliability.
Patent CN113912556B reveals a novel Cu-catalyzed oxidative coupling route for alpha,beta-dicarbonyl-1,2,3-triazoles, offering significant cost reduction in API manufacturing.
Novel synthesis of perfluoroalkyl aromatic hydroxylamine via copper-catalyzed coupling. High-purity intermediate for fluorocarbon catalysts and pharmaceutical applications.
Patent CN107235910B reveals a high-purity synthesis route for Nilotinib intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Novel photocatalytic synthesis for bicyclo pentane derivatives. Efficient C-sp3-C-sp2 coupling. Cost-effective supply chain solution for pharma intermediates.
Patent CN118754905B reveals nickel catalysis for silane synthesis. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chain.
Novel 3,5-dialkyl pyrazole ligand enables C-Cl greater than C-OTf selectivity in Buchwald-Hartwig reactions, offering cost-effective pharma intermediate synthesis.
Patent CN110372544B details a cost-effective iron-titanium catalytic system for biaryl synthesis, offering significant supply chain stability and reduced environmental impact.
Patent CN112939829A reveals a copper-catalyzed method for aryl trifluoromethyl thioethers, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN110143982A reveals green synthesis. Cost reduction and supply reliability for high-purity organophosphorus intermediates in global markets.
Patent CN101891647A details a novel Ubenimex preparation using L-lysine resolution and EDCI/HOAt coupling, ensuring >99.5% purity and robust supply chain reliability.